e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Pulmonary rehabilitation for non-obstructive lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
S. Banerjee (kent, United Kingdom), s. rajput (kent, United Kingdom)
Source:
International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Session:
Pulmonary rehabilitation for non-obstructive lung diseases
Session type:
Thematic Poster
Number:
675
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Banerjee (kent, United Kingdom), s. rajput (kent, United Kingdom). Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review. 675
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
Related content which might interest you:
Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference?
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Effect of Pulmonary Rehabilitation on Functional Exercise Capacity and Hypoxemia in Patients with Interstitial Lung Diseases: a retrospective study
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Integrating Ambulatory Oxygen assessments into a specialist Interstitial Lung Disease (ILD) clinic
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1
Year: 2020
Treatment of IPF with inhaled IFN-gamma; planning for a clinical trial
Source: International Congress 2014 – ILDs 3
Year: 2014
Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014
Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
What motivates primary healthcare practitioners to refer patients with Chronic Obstructive Pulmonary Disease (COPD) to Pulmonary Rehabilitation? A survey using the Theoretical Domains Framework.
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020
Pirfenidone post-authorization safety registry (PASSPORT) – Interim analysis of IPF treatment
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
Selection of patients from Pulmonary Rehabilitation (PR) to Disease Management (DM) programmes
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Associated Factors with the Approval of Pulmonary Rehabilitation for Inpatients with Interstitial Lung Disease: Two-center Retrospective Study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD): an international research prioritisation
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
LATE-BREAKING ABSTRACT: Current management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
Does Pulmonary Rehabilitation improve people’s experience of living with Chronic Obstructive Pulmonary Disease? A Retrospective Case Note Review
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study
Source: International Congress 2014 – Sarcoidosis
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept